-
Could this be the key that unlocks stem cell treatments for MS?
The FDA has approved this clinical trial under a new designation called regenerative medicine advanced therapy (RMAT). The idea of RMAT “is to promote therapies in regenerative medicine that show the greatest potential.”
Read what else Ed Tobias has to say about this here: “Is This the Key that Unlocks Stem Cell Treatments for MS?”
Could this be a new possible way to treat MS?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.